Table 2.

Association of the lead variants at 23 known loci with natural log-transformed plasma fibrinogen concentration (g/l)

LocusVariantPositionClosest geneeQTLNSYN variantsA1/A2FrequencyβP-values
1p31.3rs189253466 105 944LEPRT/C0.38−0.00734.3 × 10−15
1q21.3rs61812598154 420 087IL6RIL6RA/G0.39−0.01152.7 × 10−36
1q44rs10157379247 605 599NLRP3NLRP3C/T0.38−0.01036.3 × 10−29
2q12rs1558643102 731 691IL1R1T/C0.400.00583.1 × 10−10
2q13rs6734238113 841 030IL1F10IL1RNG/A0.410.01066.7 × 10−30
2q34rs715211 543 055CPS1CPS1C/T0.32−0.00824.3 × 10−16
2q37.3rs59104589242 237 902HDLBPSTK25T/C0.34−0.00838.2 × 10−19
3q22.2rs9840812135 843 162PPP2R3APCCBC/T0.230.01171.7 × 10−27
4p16.3rs599502803 452 345HGFACA/G0.340.00751.7 × 10−12
4q31.3rs7439150155 481 541FGBFBGA/G0.200.03139.5 × 10−181
5q31.1rs2057655131 807 624C5orf56SLC22A4A/G0.21−0.02031.8 × 10−73
7p21.17:1790445217 904 452SNX13R/D0.480.00671.3 × 10−13
7p15.3rs7152038622 853 521TOMM7T/C0.200.00665.1 × 10−09
8q24.3rs11780978145 034 852PLECGRINAA/G0.400.00595.5 × 10−10
10q21.3rs791686864 988 931JMJD1CA/T0.490.00891.6 × 10−22
11q12.2rs1123020159 996 994MS4A6AMS4A6AG/C0.41−0.00574.5 × 10−10
12q13.12rs273143951 060 350DIP2BDIP2BT/C0.36−0.00648.7 × 10−12
14q24.1rs36767769 273 090ZFP36L1G/A0.220.00771.8 × 10−12
15q21.2rs1291325951 014 716SPPL2AT/C0.30−0.00682.3 × 10−12
16q12.2rs1185951753 181 247CHD9T/C0.29−0.00748.9 × 10−14
20q13.12rs180096143 042 364HNF4AHNF4AT/C0.03−0.01701.2 × 10−10
21q22.2rs980865140 466 468PSMG1A/G0.27−0.00952.5 × 10−20
22q13.33rs7534784351 112 361SHANK3ARSAA/G0.190.00841.8 × 10−10
LocusVariantPositionClosest geneeQTLNSYN variantsA1/A2FrequencyβP-values
1p31.3rs189253466 105 944LEPRT/C0.38−0.00734.3 × 10−15
1q21.3rs61812598154 420 087IL6RIL6RA/G0.39−0.01152.7 × 10−36
1q44rs10157379247 605 599NLRP3NLRP3C/T0.38−0.01036.3 × 10−29
2q12rs1558643102 731 691IL1R1T/C0.400.00583.1 × 10−10
2q13rs6734238113 841 030IL1F10IL1RNG/A0.410.01066.7 × 10−30
2q34rs715211 543 055CPS1CPS1C/T0.32−0.00824.3 × 10−16
2q37.3rs59104589242 237 902HDLBPSTK25T/C0.34−0.00838.2 × 10−19
3q22.2rs9840812135 843 162PPP2R3APCCBC/T0.230.01171.7 × 10−27
4p16.3rs599502803 452 345HGFACA/G0.340.00751.7 × 10−12
4q31.3rs7439150155 481 541FGBFBGA/G0.200.03139.5 × 10−181
5q31.1rs2057655131 807 624C5orf56SLC22A4A/G0.21−0.02031.8 × 10−73
7p21.17:1790445217 904 452SNX13R/D0.480.00671.3 × 10−13
7p15.3rs7152038622 853 521TOMM7T/C0.200.00665.1 × 10−09
8q24.3rs11780978145 034 852PLECGRINAA/G0.400.00595.5 × 10−10
10q21.3rs791686864 988 931JMJD1CA/T0.490.00891.6 × 10−22
11q12.2rs1123020159 996 994MS4A6AMS4A6AG/C0.41−0.00574.5 × 10−10
12q13.12rs273143951 060 350DIP2BDIP2BT/C0.36−0.00648.7 × 10−12
14q24.1rs36767769 273 090ZFP36L1G/A0.220.00771.8 × 10−12
15q21.2rs1291325951 014 716SPPL2AT/C0.30−0.00682.3 × 10−12
16q12.2rs1185951753 181 247CHD9T/C0.29−0.00748.9 × 10−14
20q13.12rs180096143 042 364HNF4AHNF4AT/C0.03−0.01701.2 × 10−10
21q22.2rs980865140 466 468PSMG1A/G0.27−0.00952.5 × 10−20
22q13.33rs7534784351 112 361SHANK3ARSAA/G0.190.00841.8 × 10−10

eQTL indicates the gene with the strongest significant association between its expression levels in blood and the lead variant or its proxy. NSYN variants indicates genes containing non-synonymous variant correlated to the lead variant (R2 > 0.9). A1 indicates the coded allele. A2 indicates the other allele. Frequency is the frequency of the coded allele. β indicates the β-coefficient adjusted for age, sex, population structure and study-specific covariates, such as center or case/control status. The β-coefficient can be interpreted as the ln(g/l) change in fibrinogen per 1 unit change in the dosage of the coded allele.

Table 2.

Association of the lead variants at 23 known loci with natural log-transformed plasma fibrinogen concentration (g/l)

LocusVariantPositionClosest geneeQTLNSYN variantsA1/A2FrequencyβP-values
1p31.3rs189253466 105 944LEPRT/C0.38−0.00734.3 × 10−15
1q21.3rs61812598154 420 087IL6RIL6RA/G0.39−0.01152.7 × 10−36
1q44rs10157379247 605 599NLRP3NLRP3C/T0.38−0.01036.3 × 10−29
2q12rs1558643102 731 691IL1R1T/C0.400.00583.1 × 10−10
2q13rs6734238113 841 030IL1F10IL1RNG/A0.410.01066.7 × 10−30
2q34rs715211 543 055CPS1CPS1C/T0.32−0.00824.3 × 10−16
2q37.3rs59104589242 237 902HDLBPSTK25T/C0.34−0.00838.2 × 10−19
3q22.2rs9840812135 843 162PPP2R3APCCBC/T0.230.01171.7 × 10−27
4p16.3rs599502803 452 345HGFACA/G0.340.00751.7 × 10−12
4q31.3rs7439150155 481 541FGBFBGA/G0.200.03139.5 × 10−181
5q31.1rs2057655131 807 624C5orf56SLC22A4A/G0.21−0.02031.8 × 10−73
7p21.17:1790445217 904 452SNX13R/D0.480.00671.3 × 10−13
7p15.3rs7152038622 853 521TOMM7T/C0.200.00665.1 × 10−09
8q24.3rs11780978145 034 852PLECGRINAA/G0.400.00595.5 × 10−10
10q21.3rs791686864 988 931JMJD1CA/T0.490.00891.6 × 10−22
11q12.2rs1123020159 996 994MS4A6AMS4A6AG/C0.41−0.00574.5 × 10−10
12q13.12rs273143951 060 350DIP2BDIP2BT/C0.36−0.00648.7 × 10−12
14q24.1rs36767769 273 090ZFP36L1G/A0.220.00771.8 × 10−12
15q21.2rs1291325951 014 716SPPL2AT/C0.30−0.00682.3 × 10−12
16q12.2rs1185951753 181 247CHD9T/C0.29−0.00748.9 × 10−14
20q13.12rs180096143 042 364HNF4AHNF4AT/C0.03−0.01701.2 × 10−10
21q22.2rs980865140 466 468PSMG1A/G0.27−0.00952.5 × 10−20
22q13.33rs7534784351 112 361SHANK3ARSAA/G0.190.00841.8 × 10−10
LocusVariantPositionClosest geneeQTLNSYN variantsA1/A2FrequencyβP-values
1p31.3rs189253466 105 944LEPRT/C0.38−0.00734.3 × 10−15
1q21.3rs61812598154 420 087IL6RIL6RA/G0.39−0.01152.7 × 10−36
1q44rs10157379247 605 599NLRP3NLRP3C/T0.38−0.01036.3 × 10−29
2q12rs1558643102 731 691IL1R1T/C0.400.00583.1 × 10−10
2q13rs6734238113 841 030IL1F10IL1RNG/A0.410.01066.7 × 10−30
2q34rs715211 543 055CPS1CPS1C/T0.32−0.00824.3 × 10−16
2q37.3rs59104589242 237 902HDLBPSTK25T/C0.34−0.00838.2 × 10−19
3q22.2rs9840812135 843 162PPP2R3APCCBC/T0.230.01171.7 × 10−27
4p16.3rs599502803 452 345HGFACA/G0.340.00751.7 × 10−12
4q31.3rs7439150155 481 541FGBFBGA/G0.200.03139.5 × 10−181
5q31.1rs2057655131 807 624C5orf56SLC22A4A/G0.21−0.02031.8 × 10−73
7p21.17:1790445217 904 452SNX13R/D0.480.00671.3 × 10−13
7p15.3rs7152038622 853 521TOMM7T/C0.200.00665.1 × 10−09
8q24.3rs11780978145 034 852PLECGRINAA/G0.400.00595.5 × 10−10
10q21.3rs791686864 988 931JMJD1CA/T0.490.00891.6 × 10−22
11q12.2rs1123020159 996 994MS4A6AMS4A6AG/C0.41−0.00574.5 × 10−10
12q13.12rs273143951 060 350DIP2BDIP2BT/C0.36−0.00648.7 × 10−12
14q24.1rs36767769 273 090ZFP36L1G/A0.220.00771.8 × 10−12
15q21.2rs1291325951 014 716SPPL2AT/C0.30−0.00682.3 × 10−12
16q12.2rs1185951753 181 247CHD9T/C0.29−0.00748.9 × 10−14
20q13.12rs180096143 042 364HNF4AHNF4AT/C0.03−0.01701.2 × 10−10
21q22.2rs980865140 466 468PSMG1A/G0.27−0.00952.5 × 10−20
22q13.33rs7534784351 112 361SHANK3ARSAA/G0.190.00841.8 × 10−10

eQTL indicates the gene with the strongest significant association between its expression levels in blood and the lead variant or its proxy. NSYN variants indicates genes containing non-synonymous variant correlated to the lead variant (R2 > 0.9). A1 indicates the coded allele. A2 indicates the other allele. Frequency is the frequency of the coded allele. β indicates the β-coefficient adjusted for age, sex, population structure and study-specific covariates, such as center or case/control status. The β-coefficient can be interpreted as the ln(g/l) change in fibrinogen per 1 unit change in the dosage of the coded allele.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close